Dermatology · Columbus, OH
NPI
1205911898
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
170 Northwoods Blvd, Suite 10
Columbus, OH, 43235
Phone (614) 436-7188
Groups this clinician bills Medicare through
Medicare paid, 2024
$225K
5,932 services
Medicare patients, 2024
1,203
Average age 76
Drug cost, 2024
$297K
2,515 prescriptions
Company payments, 2025
$881
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew D Quillin was code 17003 (destruction skin lesion), 2,278 times for 462 patients. In total Andrew D Quillin billed 5,932 services in 61 codes, and Medicare paid $225K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,278 | 462 | $4.36 | $9,940 |
| 99213 Office E&M - Established | Office | 915 | 733 | $54.39 | $50K |
| 17000 Destruction Skin Lesion | Office | 770 | 633 | $36.02 | $28K |
| 99214 Office E&M - Established | Office | 584 | 452 | $78.22 | $46K |
| 11102 Skin Biopsy | Office | 278 | 235 | $60.00 | $17K |
| 17110 Destruction Skin Lesion | Office | 226 | 210 | $69.57 | $16K |
| 99212 Office E&M - Established | Office | 163 | 150 | $35.99 | $5,867 |
| 11103 Skin Biopsy | Office | 111 | 73 | $35.33 | $3,921 |
| 11301 Removal or Shaving of Skin Growth | Office | 74 | 65 | $74.07 | $5,481 |
| 17262 Destruction Skin Lesion | Office | 71 | 54 | $116.61 | $8,279 |
| 99203 Office E&M - New | Office | 49 | 49 | $63.60 | $3,117 |
| 17261 Destruction Skin Lesion | Office | 31 | 24 | $91.94 | $2,850 |
| 17111 Destruction Skin Lesion | Office | 29 | 25 | $84.13 | $2,440 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 26 | 22 | $0.69 | $17.88 |
| 17004 Destruction Skin Lesion | Office | 22 | 20 | $102.62 | $2,258 |
By year: 2022 $224K for 5,029 services; 2023 $239K for 5,976 services; 2024 $225K for 5,932 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew D Quillin prescribed most often to Medicare patients was Minoxidil, with 354 prescriptions and refills. In total Andrew D Quillin wrote 2,515 Medicare prescriptions that cost $297K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Minoxidil Generic | 354 | 1,030 | 119 | $4,194 |
| Finasteride Generic | 314 | 932 | 101 | $3,797 |
| Hydrocortisone Generic | 173 | 190 | 112 | $857 |
| Fluocinonide Generic | 173 | 187 | 108 | $5,704 |
| Triamcinolone Acetonide Generic | 141 | 163 | 91 | $1,324 |
| Ketoconazole Generic | 130 | 200 | 66 | $3,456 |
| Clobetasol Propionate Generic | 118 | 138 | 65 | $5,345 |
| Spironolactone Generic | 109 | 321 | 37 | $1,858 |
| Mupirocin Generic | 99 | 101 | 62 | $769 |
| Metronidazole Generic | 86 | 104 | 45 | $3,548 |
| Doxycycline Hyclate Generic | 73 | 100 | 40 | $1,383 |
| Gabapentin Generic | 61 | 121 | 21 | $1,012 |
| Valacyclovir Valacyclovir Hcl | 58 | 101 | 24 | $1,567 |
| Cephalexin Generic | 56 | 56 | 52 | $491 |
| Fluorouracil Generic | 51 | 52 | 51 | $3,259 |
Brand drugs: 70 claims; generic drugs: 2,445 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew D Quillin $881 ($881 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $415.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 29 | $415 |
| Janssen Biotech, Inc. JNJ | 6 | $185 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $72.28 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $70.41 |
| UCB, Inc. UCB.BR | 3 | $48.15 |
| Galderma Laboratories, L.P. GALD.SW | 2 | $27.88 |
| Lilly USA, LLC LLY | 1 | $23.69 |
| Genzyme Corporation SNY | 1 | $19.62 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.